Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Pancreatic Cancer

Trial Information

Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer

Official Title: Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer

Summary

The purpose of this study is to determine if the combination of Gemcitabine, Oxaliplatin and Erlotinib in the treatment of patients with pancreatic cancer will provide increased clinical benefits and improvement in their quality of life.

Phase: Phase 2

Sponsor: National Guard Health Affairs

Overall Contacts:

Oncology Research
009661-2520088 ext. 14601

Locations (1)

Country State City Zip Facility and Contact
Saudi Arabia Riyadh 9661 National Guard Health Affairs
Marie D Gretchen, Admin
009661-2520088 ext. 14171
datariom@ngha.med.sa

Abdul-Rahman M Jazieh, MD,MPH
Principal Investigator

NCT ID:NCT00636883

Date Last Changed: March 27, 2011